ture collaboration agreements, economic performance and
trends, the success of the Company's development, events conditioned on
stockholder or other approval, or otherwise as to future events, such
statements are forward looking, all forward-looking statements, whether
written or oral, and whether made by or on behalf of the Company, are
expressly qualified by the cautionary statements and any other cautionary
statements, which may accompany the forward-looking statements, and are
made pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933
and Section 21E of the Securities Exchange Act of 1934. Forward-looking
information is inherently subject to risks and uncertainties, and actual
results could differ materially from those currently anticipated due to a
number of factors, which include, but are not limited to, risk factors
inherent in doing business. Forward-looking statements may be identified by
terms such as "may," "will," "should," "could," "expects," "plans,"
"intends," "anticipates," "believes," "estimates," "predicts," "forecasts,"
"potential," or "continue," or similar terms or the negative of these
terms. Although we believe that the expectations reflected in the
forward-looking statements are reasonable, we cannot guarantee future
results, levels of activity, performance or achievements. The company has
no obligation to update these forward-looking statements. Other important
factors that could cause actual results to differ materially include the
following: business conditions and the amount of growth in the Company's
industry and general economy; government policies, competitive factors;
ability to attract and retain personnel; the price of the Company's stock;
and the risk factors set forth from time to time in the Company's SEC
reports, including but not limited to its annual report on Form 10-KSB; its
quarterly reports on Forms 10-QSB; and any reports on Form 8-K. In
a
'/>"/>SOURCE China Holdings, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 Related medicine news :1.
China Display Technologies, Inc. to Present at Roth Conference2.
Renowned Chinese Herbal Medicine Development Specialist Joins China Health Resources3.
Wall Street Reporter Spotlights China Holdings Inc. and Asias Hunger for Alternative Energy4.
Chinas Environment, Health Examined in New Wilson Center Report5.
Red Cross Partners with YeePay on China Snow Disaster Relief6.
China Sky One Medical Raises $25 Million in Private Placement7.
DuPont Opens Fluoropolymer Production Plant in China8.
China Pharma Holdings, Inc. Receives Chinese SFDA Approval for Generic Bumetanide Injection9.
China Medical Technologies to Announce Financial Results for the Third Quarter Ended December 31, 2007 on February 28, 200810.
China Nepstar Chain Drugstore Launches Charitable Initiative to Promote Awareness of Low-income Working Womens Health Issues11.
Access Licenses MuGard(TM) to RHEI Pharmaceuticals, a Leading Specialty Pharmaceutical Company for Distribution in China and Certain Other Southeast Asian Countries